PT1761524E - Fenilpiperazina- e fenildiazepano-carboxamidas, fundidas com anel contendo oxigénio, utilizadas como antagonistas de dopamina d3 - Google Patents

Fenilpiperazina- e fenildiazepano-carboxamidas, fundidas com anel contendo oxigénio, utilizadas como antagonistas de dopamina d3 Download PDF

Info

Publication number
PT1761524E
PT1761524E PT05823871T PT05823871T PT1761524E PT 1761524 E PT1761524 E PT 1761524E PT 05823871 T PT05823871 T PT 05823871T PT 05823871 T PT05823871 T PT 05823871T PT 1761524 E PT1761524 E PT 1761524E
Authority
PT
Portugal
Prior art keywords
carboxamides
phenyl
diazepane
dopamine
antagonists
Prior art date
Application number
PT05823871T
Other languages
English (en)
Inventor
Peter Gmeiner
Harald Huebner
Karin Schlotter
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of PT1761524E publication Critical patent/PT1761524E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Addiction (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • External Artificial Organs (AREA)
PT05823871T 2004-12-30 2005-12-27 Fenilpiperazina- e fenildiazepano-carboxamidas, fundidas com anel contendo oxigénio, utilizadas como antagonistas de dopamina d3 PT1761524E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004063797A DE102004063797A1 (de) 2004-12-30 2004-12-30 Sauerstoffhaltige annelierte Phenylpiperazin- und Phenyldiazepancarboxamide

Publications (1)

Publication Number Publication Date
PT1761524E true PT1761524E (pt) 2008-02-21

Family

ID=36102609

Family Applications (1)

Application Number Title Priority Date Filing Date
PT05823871T PT1761524E (pt) 2004-12-30 2005-12-27 Fenilpiperazina- e fenildiazepano-carboxamidas, fundidas com anel contendo oxigénio, utilizadas como antagonistas de dopamina d3

Country Status (22)

Country Link
US (1) US20080194539A1 (pt)
EP (1) EP1761524B1 (pt)
JP (1) JP2008526700A (pt)
KR (1) KR20070102673A (pt)
CN (1) CN101027294A (pt)
AU (1) AU2005324107A1 (pt)
BR (1) BRPI0519485A2 (pt)
CA (1) CA2576332A1 (pt)
DE (2) DE102004063797A1 (pt)
DK (1) DK1761524T3 (pt)
EA (1) EA200701366A1 (pt)
ES (1) ES2297767T3 (pt)
HK (1) HK1100845A1 (pt)
HR (1) HRP20080075T3 (pt)
IL (1) IL180763A0 (pt)
MX (1) MX2007006369A (pt)
NO (1) NO20072587L (pt)
PL (1) PL1761524T3 (pt)
PT (1) PT1761524E (pt)
SI (1) SI1761524T1 (pt)
WO (1) WO2006072430A1 (pt)
ZA (1) ZA200701972B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9227944B2 (en) 2008-10-10 2016-01-05 Institute Of Pharmacology And Toxicology Academy Of Military Science P.L.A. China Dopamine D3 receptor ligands and preparation and medical uses of the same
WO2010040274A1 (zh) * 2008-10-10 2010-04-15 中国人民解放军军事医学科学院毒物药物研究所 新型多巴胺d3受体配体,其制备方法及其医药用途
UY32481A (es) * 2009-03-10 2010-09-30 Takeda Pharmaceutical Derivados de benzofurano
ES2729824T3 (es) * 2011-04-08 2019-11-06 Laurus Labs Ltd Formas sólidas de compuestos antirretrovirales, procedimiento para la preparación y composición farmacéutica de los mismos

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL90279A (en) * 1988-05-24 1995-03-30 American Home Prod History of piperazinyl carboxamide, their preparation and the pharmaceutical preparations containing them
CA2004670A1 (en) * 1988-12-08 1990-06-08 Jan Hartog Anxiolytically active piperazine derivatives
DE4127849A1 (de) * 1991-08-22 1993-02-25 Merck Patent Gmbh Benzodioxanderivate
DE4333254A1 (de) * 1993-09-30 1995-04-06 Merck Patent Gmbh Piperidine und Piperazine
EP1007523B9 (en) * 1997-07-25 2004-09-08 H. Lundbeck A/S Indole and 2,3-dihydroindole derivatives, their preparation and use
FR2781671A1 (fr) * 1998-07-28 2000-02-04 Synthelabo Compositions pharmaceutiques contenant un inhibiteur de la recapture de la serotonine et leur application en therapeutique
AR022303A1 (es) * 1999-01-22 2002-09-04 Lundbeck & Co As H Derivados de piperidina, tetrahidropiridina y piperazina, su preparacion y utilizacion
GB9905010D0 (en) * 1999-03-04 1999-04-28 Merck Sharp & Dohme Therapeutic agents
ES2188344B1 (es) * 2000-11-29 2004-09-16 Laboratorios Vita, S.A. Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismos.
HUP0103987A3 (en) * 2001-09-28 2004-11-29 Richter Gedeon Vegyeszet Phenylpiperazinylalkyl carboxylic acid amid derivatives, process for their preparation, pharmaceutical compositions containing them and their intermediates
KR20050075281A (ko) * 2002-07-04 2005-07-20 쉬바르츠파르마에이지 씨엔에스 질병의 치료를 위한 도파민-디3 리간드로서헤테로아렌 카복스아미드의 용도
US7605259B2 (en) * 2002-09-14 2009-10-20 University Of North Texas Health Science Center At Fort Worth Structurally rigid dopamine d3 receptor selective ligands and process for making them
DE10259244A1 (de) * 2002-12-17 2004-07-01 Merck Patent Gmbh N-(Indolethyl-)cycloamin-Verbindungen
US20040192730A1 (en) * 2003-03-13 2004-09-30 Dynogen Pharmaceuticals, Inc. Methods of using compounds with combined 5-HT1A and SSRI activities as-needed to treat sexual dysfunction

Also Published As

Publication number Publication date
US20080194539A1 (en) 2008-08-14
KR20070102673A (ko) 2007-10-19
DE102004063797A1 (de) 2006-07-13
HRP20080075T3 (en) 2008-03-31
HK1100845A1 (en) 2007-09-28
SI1761524T1 (sl) 2008-04-30
CN101027294A (zh) 2007-08-29
DE502005002058D1 (de) 2008-01-03
EP1761524B1 (de) 2007-11-21
EA200701366A1 (ru) 2008-02-28
PL1761524T3 (pl) 2008-04-30
AU2005324107A1 (en) 2006-07-13
CA2576332A1 (en) 2006-07-13
IL180763A0 (en) 2007-06-03
MX2007006369A (es) 2007-07-11
JP2008526700A (ja) 2008-07-24
ES2297767T3 (es) 2008-05-01
NO20072587L (no) 2007-05-21
WO2006072430A1 (de) 2006-07-13
DK1761524T3 (da) 2008-04-07
EP1761524A1 (de) 2007-03-14
ZA200701972B (en) 2008-04-30
BRPI0519485A2 (pt) 2009-02-03
AU2005324107A2 (en) 2006-07-13

Similar Documents

Publication Publication Date Title
IL181524A0 (en) Heterocyclic compounds and methods of use
EP1790639A4 (en) A BASIC GROUP CONNECTING AND APPLYING THEREOF
EP2018863A4 (en) FUSED HETEROCYCLIC COMPOUND AND USE
HK1097269A1 (en) Tricyclic compounds and their use as mglur1 antagonists
HK1103074A1 (en) Heteroaryl-ureas and their use as glucokinase activators
GB0407114D0 (en) Polymer additives and methods of use thereof
EP2054798A4 (en) DISTRIBUTION AND MANAGEMENT OF DIFFUSION LISTS USING THE CONTENT
IL177692A0 (en) Novel carboxamides for use as xa inhibitors
EP1718621A4 (en) NITROXYL PREPARATION COMPOUNDS APPLICATION METHOD
EP2023718A4 (en) CREATINLIGATE COMPOUNDS AND APPLICATION METHOD THEREFOR
EP2104492A4 (en) OXYGEN FEED FOR A CELL TRANSPLANT AND VASCULARIZATION
EP2039184A4 (en) LOCAL USER INTERFACE COMPOSITION WITH REMOTELY GENERATED USER INTERFACE AND MULTIMEDIA MEDIA
ZA200808017B (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
ZA200809019B (en) Fused heterocylic compounds and their use as MGLUR5 modulators
IS8248A (is) Útskipt tvíketópíperasín og notkun þeirra sem oxytósínmótlyfja
EP2043686A4 (en) ANTAGONISTS OF PROTEASE-ACTIVATED RECEPTOR-1 (PAR1)
EP1997496A4 (en) COMPOSITION CONTAINING RIBOFLAVIN AND SESAME
ZA201103462B (en) Aryl piperazine and their use as alpha2c antagonists
EP1812451A4 (en) COMPOUNDS AND METHODS OF USE THEREOF
EP2099597A4 (en) RECEIVER BLOCK MOLD AND USE THEREOF
IL180763A0 (en) Phenyl diazepane carboxamides and annelated phenyl piperazine carboxamides containing oxygen and used as dopamine d3 antagonists
EP2039422A4 (en) OXYGEN STORAGE MATERIAL
EP2039695A4 (en) BICYCLIC HETEROCYLIC COMPOUND AND ITS USE
EP2069371A4 (en) ORGANO ARSENOXIDE COMPOUNDS AND THEIR USE
EP1845135A4 (en) COMPOSITION COMPOSED OF OXOCOAL SUBSTANCE AND USE THEREOF